Pronova Biopharma Norge as v. Teva Pharmaceuticals Usa, Inc.
Pronova Biopharma Norge as v. Teva Pharmaceuticals Usa, Inc.
Opinion
Case: 12-1498 Document: 47 Page: 1 Filed: 12/27/2012
NOTE: This order is nonprecedential.
United States Court of Appeals for the Federal Circuit __________________________
PRONOVA BIOPHARMA NORGE AS, Plaintiff-Appellee,
v. TEVA PHARMACEUTICALS USA, INC., Defendant-Appellant,
AND
PAR PHARMACEUTICAL, INC. AND PAR PHARMACEUTICAL COMPANIES, INC., Defendants-Appellants. __________________________
2012-1498, -1499 __________________________
Appeals from the United States District Court for the District of Delaware in consolidated case nos. 09-CV-0286 and 09-CV-0305, Judge Sue L. Robinson. __________________________
ON MOTION __________________________
ORDER
Teva Pharmaceuticals USA, Inc. (“Teva”) and Par Pharmaceutical Companies, Inc. (collectively “Par”) Case: 12-1498 Document: 47 Page: 2 Filed: 12/27/2012
PRONOVA BIOPHARMA NORGE V. TEVA PHARMACEUTICALS 2
jointly move for an extension of time, until January 16, 2013 to file their reply briefs.
Upon consideration thereof,
IT IS ORDERED THAT:
(1) The December 19, 2012 motion is granted. (2) The December 13, 2012 motion is withdrawn.
FOR THE COURT
/s/ Jan Horbaly Jan Horbaly Clerk s27
Reference
- Status
- Unpublished